

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $48.18
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Aug 3, 26 |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Jun 14, 19 | Williams Catherine Lynne | director | A-Award | 690 | — |
Daily · Wilder smoothing
| RBC Capital |
| maintain |
| Outperform |
| Outperform |
| May 11, 26 | RBC Capital | maintain | Outperform | Outperform |
| Feb 17, 26 | RBC Capital | maintain | Outperform | Outperform |
| Nov 10, 25 | RBC Capital | maintain | Outperform | Outperform |
| Aug 12, 25 | Argus Research | maintain | Buy | Buy |
| May 12, 25 | RBC Capital | maintain | Outperform | Outperform |
| Feb 18, 25 | RBC Capital | maintain | Outperform | Outperform |
| Dec 4, 24 | RBC Capital | maintain | Outperform | Outperform |
| Oct 18, 23 | Barclays | maintain | Equal Weight | Equal Weight |
| Jun 14, 19 |
| Williams Catherine Lynne |
| director |
| A-Award |
| 602 |
| — |
| Jun 14, 19 | Tutcher Dan C | director | A-Award | 1,726 | — |
| Jun 14, 19 | Tutcher Dan C | director | A-Award | 1,726 | — |
| Jun 14, 19 | Madden Teresa S | director | A-Award | 863 | — |
| Jun 14, 19 | Madden Teresa S | director | A-Award | 863 | — |
| Jun 14, 19 | Kempston Darkes V Maureen | director | A-Award | 1,792 | — |
| Jun 14, 19 | Kempston Darkes V Maureen | director | A-Award | 1,792 | — |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 54.27 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 91.69 | Oscillator | Sell |
| Williams %R (14) | -5.60 | Oscillator | Sell |
| MACD (12, 26, 9) | -0.12 (Hist 0.30) | Oscillator | Buy |
| Average Directional Index (14) | 32.53 (+DI 13.5 / -DI 19.4) | Trend | Strong Sell |
| EMA 20 | 47.53 | MA | Buy |
| SMA 20 | 46.99 | MA | Buy |
| EMA 50 | 48.71 | MA | Sell |
| SMA 50 | 48.48 | MA | Sell |
| SMA 200 | 52.15 | MA | Strong Sell |
Stock news · updated daily
Enbridge Inc. (ENB) offers a 5.8% dividend yield after recent price correction, but underlying risks limit total return potential. ENB faces constrained EPS growth (~4% CAGR through 2030) despite multiple expansion projects and acquisitions. Elevated debt ($78B, 6.3x Debt/EBITDA) and elevated borrowing rates pressure dividend coverage with forward payout exceeds projected EPS for the next five years.
With Treasury yields north of 5%, the bar for dividend stocks has never been higher, yet five companies are clearing it with cash-covered payouts and decades of consecutive raises behind them.
Social Security raises are locked to a government formula, but a growing number of retirees are routing their income strategy around it entirely, and the stocks they are buying span five very different industries.
K-1 forms arrive late, complicate tax returns, and can create UBTI headaches inside IRAs, but pipeline income does not require that tradeoff.
A rare bipartisan warning from top U.S. officials could signal a massive catalyst for overlooked high-yield dividend stocks as America races to catch China. Their concerns highlight how AI's biggest bottleneck provides a huge investment opportunity. I reveal some of my top picks to capitalize on this opportunity as well as some of the risks to keep in mind.
Enbridge, yielding nearly 6%, has a track record of dividend growth spanning over three decades. A 359-share position in Enbridge, worth around $17,268, would generate around $1,000 per year in dividend income.
CWA Asset Management Group LLC increased its stake in Enbridge Inc (NYSE: ENB) (TSE: ENB) by 15.3% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 115,750 shares of the pipeline company's stock after acquiring an additional 15,328
Rose's Income Garden portfolio review highlights 15 most undervalued and 15 most overvalued dividend stocks using 52-week high/low analysis. Energy names like XOM, SHEL, and CVX have rotated into overvalued territory, while high-yield REITs such as VICI remain top undervalued picks. Dividend yield remains a key selection criterion, with several undervalued stocks offering yields above 5% and investment-grade credit ratings.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 31, 2026 | 0.43 | 0.46 | Beat 7.0% | $20.64B |
| May 8, 2026 | 0.69 | 0.71 | Beat 2.9% | $16.07B |
| Feb 13, 2026 | 0.60 | 0.63 | Beat 5.0% | $12.51B |
| Nov 7, 2025 | 0.39 | 0.33 | Miss -15.4% | $14.64B |
| Aug 1, 2025 | 0.41 | 0.47 | Beat 14.6% | $10.88B |
| May 9, 2025 | 0.68 | 0.72 | Beat 5.9% | $12.99B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| SD | Sep 23, 2026 | 2026-09-23 11:20:41 | View |
| 8-K | Sep 14, 2026 | 2026-09-14 08:26:44 | View |
| 424B5 | Sep 10, 2026 | 2026-09-10 09:17:41 | View |
| FWP | Sep 10, 2026 | 2026-09-09 18:52:42 | View |
| 8-K | Sep 9, 2026 | 2026-09-09 17:26:13 | View |
| 424B5 | Sep 9, 2026 | 2026-09-09 16:25:42 | View |
| 8-K | Sep 9, 2026 | 2026-09-09 16:23:21 | View |
| 8-K | Sep 8, 2026 | 2026-09-08 16:04:43 | View |
| S-8 | Jul 31, 2026 | 2026-07-31 16:17:38 | View |
| 10-Q | Jul 31, 2026 | 2026-07-31 07:05:49 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | ENB | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 22.5x | 24.3x · sector 14.8x | Elevated |
| Forward P/E (FY26E) | 16.4x | EPS est. 2.93 | Discount |
| Price / Book | 2.3x | 1.7x | Elevated |
| Price / Sales | 1.5x | 2.2x | Discount |
| EV / EBITDA | 13.0x | 13.2x | In line |
| Return on equity | 10.0% | — | Healthy |
| Gross margin | 28.2% | 34.2% | Below hist. |
| Debt / Equity | 1.72 | 1.43 | Levered |
| Piotroski / Altman Z | 5/9 | Z 0.94 | Distress |
Discounted cash flow model
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure